Tafasitamab

Status:
Do Not Prescribe (DNP)
Decision Date:
June 2023
 

Comments

DNP: NICETA883- Tafasitamab with lenalidomide for treating relapsed or refractory diffuse large B-cell lymphoma. NHSE commissioned. 

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app